ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy

Gu, Liwei; Zhang, Jiaxing; Liu, Dandan; Chen, Jiayun; Liu, Shuzhi; Peng, Qing; Tian, Ya; Du, Maobo; Zhang, Junzhe; Xiao, Wei; Shen, Shuo*; Wang, Jigang*南方医科大学
JOURNAL OF NANOBIOTECHNOLOGY2022-8-13DOI: 10.1186/s12951-022-01569-5
8被引13阅读
引用收藏
分享

摘要

Breast cancer is the leading cause of cancer-related deaths in women and remains a formidable therapeutic challenge. Mitochondria participate in a myriad of essential cellular processes, such as metabolism, and are becoming an ideal target for cancer therapy. Artemisinin and its derivatives have demonstrated multiple activities in the context of various cancers. Mitochondrial autophagy(mitophagy) is one of the important anti-tumor mechanisms of artemisinin drugs. However, the lack of specific tumor targeting ability limits the anti-tumor efficacy of artemisinin drugs. In this study, a GSH-sensitive artesunate smart conjugate (TPP-SS-ATS) was synthesized and liposomes (TPP-SS-ATS-LS) that target tumor cells and mitochondria were further prepared. The advantages of TPP-SS-ATS-LS targeting to the breast tumor were verified by in vivo and in vitro evaluations. In our study, the cytotoxicity was obviously enhanced in vitro and tumor growth inhibition rate was increased from 37.7% to 56.4% at equivalent artesunate dosage in breast cancer orthotopic implanted mice. Meanwhile, mitochondrial dysfunction, suppression of ATP production and respiratory capacity were detected in breast cancer cells. We further discovered that TPP-SS-ATS-LS inhibited tumor cells proliferation through mitophagy by regulating PHB2 and PINK1 These results provide new research strategies for the development of new artemisinin-based anti-tumor drugs.

学科与关键词

关键词
Artesunate smart conjugateMitochondrial targetingLiposomesAnti-tumorMitophagy
相关
加载中…
  • Mitochondrial-Targeted Triphenylphosphonium-Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation
    Zhang, Kunfeng; Fu, Jingxin; Liu, Xiaorui; Guo, Yifei; Han, Meihua; Liu, Meifeng*; Wang, Xiangtao*Pharmaceutics, 2023, 15(2): 388.被引 2
  • Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment
    Wang, Youke; Yuan, Xiang; Ren, Min*; Wang, Zhiyu*AMERICAN JOURNAL OF CHINESE MEDICINE, 2024.
  • Discovery of PlatinumIV-Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents
    Liu, Wei; Yu, Chuyi; Wang, Miaomiao; He, Youyou; Guo, Zhongjie; He, Jin; Jiang, Ru; Xu, Qin; Liang, Jianming*; Wang, Shengzheng*Journal of Medicinal Chemistry, 2023.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF NANOBIOTECHNOLOGY
发表日期
2022-08-13
卷期
第 20 卷, 第 1 期
页码
376
DOI
10.1186/s12951-022-01569-5
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Scientific and technological innovation project of China Academy of Chinese Medical Sciences [CI2021A04311, CI2021A04307]; Fundamental Research Funds for the Central public welfare research institutes [ZZ13-YQ-103, ZZ13-YQ-108]; National Natural Science Foundation of China [82141001, 81603346]; Cultivation Project of National Natural Science Foundation of China [LQH20004]

作者

  • G

    Gu, Liwei (第一作者)

  • Z

    Zhang, Jiaxing

    southern med univ

查看全部 12 位作者收起作者
  • L

    Liu, Dandan

  • C

    Chen, Jiayun

  • L

    Liu, Shuzhi

  • P

    Peng, Qing

    xiyuan hosp

  • T

    Tian, Ya

  • D

    Du, Maobo

  • Z

    Zhang, Junzhe

  • X

    Xiao, Wei

    southern med univ

  • S

    Shen, Shuo (通讯)

  • W

    Wang, Jigang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417